SUZHOU, China, March 11, 2026 /PRNewswire/ — Alphamab Oncology (stock code: 9966.HK) announced the appointment of Dr. Hongwei Wang as Chief Technology Officer (CTO). Dr. Wang will be responsible for the company's Process Development and Analytical Development Department, Production Department and Quality Department, and report to Dr. Ting Xu, Chairman and CEO of Alphamab Oncology. Dr. Hongwei Wang is a seasoned expert in biopharmaceutical CMC (Chemistry, Manufacturing, and Controls) development and commercial manufacturing management, with extensive industry experience. Dr. Wang's joining will accelerate the global development and commercialization of the company's innovative product pipeline. Prior to joining Alphamab Oncology, Dr….